Brief: Vertex Scientists Awarded The 2025 Lasker~Debakey Clinical Medical Research Award
Sept 11 (Reuters) - Vertex Pharmaceuticals Inc VRTX.O: VERTEX SCIENTISTS AWARDED THE 2025 LASKER~DEBAKEY CLINICAL MEDICAL RESEARCH AWARD FOR PIONEERING DISCOVERIES IN CYSTIC FIBROSIS Source text: ID:nBw7nZy8Va Further company coverage: VRTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vertex Pharmaceuticals
See all newsBrief: Vertex Announces US FDA Acceptance Of Biologics License Application For Accelerated Approval Of Povetacicept In IgA Nephropathy
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings
Vertex Q1 adjusted EPS beats estimates, revenue rises 8%
Vertex tops profit estimates as sales of new cystic fibrosis drug surge
Brief: Vertex Pharmaceuticals Q1 Adjusted EPS USD 4.47 Vs. IBES Estimate USD 4.31